Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –
Novartis Operating Lease Assets: $1,570M in FY2025, up 11.0% from a year earlier.
Latest, FY2025
1,570
Period ended Dec 31, 2025
Change on a year earlier
+11.0%
1,415 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Reported in Postgres DB + Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating Lease Assets ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,570 | +11.0% | Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 1,415 | +0.4% | Novartis 20-F (0001370368-25-000004, filed 2025-01-31) ↗ |
| FY2023 | Dec 31, 2023 | 1,410 | -1.5% | Novartis 20-F (0001370368-24-000004, filed 2024-01-31) ↗ |
| FY2022 | Dec 31, 2022 | 1,431 | -8.3% | Novartis 20-F (0001370368-23-000006, filed 2023-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 1,561 | -6.9% | Novartis 20-F (0001370368-22-000010, filed 2022-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 1,676 | -0.1% | Novartis 20-F (0001370368-21-000006, filed 2021-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 1,677 | +8.2% | Novartis 20-F (0001370368-20-000003, filed 2020-01-29) ↗ |
| FY2018 | Dec 31, 2018 | 1,550 | – | Novartis 20-F (0001370368-22-000010, filed 2022-02-02) ↗ |
Cite this data
StockData. (2026). Novartis Operating Lease Assets ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-rou
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.